CD3 Labs ASBL
43.5 FTEThe score of CD3 Labs shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +3 % Equity -14 % Total assets +2 % Headcount (avg FTE) +12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CD3 Labs's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €10.00m | ||||
| Net result | −118,898 € | ||||
| Equity | 21,267 € | ||||
| Cash | 286,100 € | ||||
| EBITDA | −111,281 € | ||||
| Total assets | €1.79m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 27 May 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 18 May 2022
CD3 Labs's financial analysis
- Solvency1.2%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CD3 Labs
CD3 Labs's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0888.594.828
- VAT number
- BE0888594828
- Peppol
- Registered · 0208:0888594828 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 30 Mar 2007
- Registered office
- 3001 Leuven
- Size
- Small · 43.5 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
CD3 Labs (ASBL) has been based in Leuven since 2007, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports revenue of €10.00m, a net loss of 118,898 € and equity of 21,267 €. With 43.5 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 1.2%, below the median of its sector (60.4%).
Companies similar to CD3 Labs
Companies in the same business, of comparable size and area, outside its group.
- Institut DE Securite Incendie - Instituut Voor Brandveiliging Research and experimental development on natural sciences and engineering Liège · balance sheet 342,047 €
- Centre Pilote wallon des Céréales et Oléo-protéagineux Research and experimental development on natural sciences and engineering Gembloux · balance sheet 843,824 €
- European Marine Board Research and experimental development on natural sciences and engineering Ostend · balance sheet €1.70m
- Societe Internationale DE LA Science Horticole - I.S.H.S. - International Society FOR Horticultural Science Research and experimental development on natural sciences and engineering Bierbeek · balance sheet €1.52m
- Centre de Recherche,d'Etude et de Formation Continue de la HELHA Research and experimental development on natural sciences and engineering Mons · balance sheet €2.52m
- Cercles des Naturalistes de Belgique Research and experimental development on natural sciences and engineering Viroinval · balance sheet €1.90m
- Eurogeosurveys Research and experimental development on natural sciences and engineering Brussels · balance sheet €1.91m
- Data, AI and Robotics (DAIRO) Research and experimental development on natural sciences and engineering Brussels · balance sheet €2.99m
Frequently asked questions about CD3 Labs
What is the revenue of CD3 Labs?
According to the 2025 annual accounts filed with the NBB, the revenue of CD3 Labs amounts to 9,997,131 €.
What is the VAT number of CD3 Labs?
In Belgium, the VAT number is the company number prefixed with BE: BE0888594828 for CD3 Labs, if the company is VAT-registered. Its company number (CBE) is 0888.594.828.
Where is the registered office of CD3 Labs?
According to the CBE register, the registered office of CD3 Labs is in 3001 Leuven.
What is the equity of CD3 Labs?
At the close of the 2025 financial year, the equity of CD3 Labs amounts to 21,267 €, a solvency of 1.2% of total assets.
How many people work at CD3 Labs?
43.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages CD3 Labs?
The register lists 4 active mandates at CD3 Labs. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CD3 Labs
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →